Evidence map›Paper›PMID 26492277›Full record

ArticleBiomolecules2015

HIV-1 Recruits UPF1 but Excludes UPF2 to Promote Nucleocytoplasmic Export of the Genomic RNA.

Lara Ajamian, Karen Abel, Shringar Rao, Kishanda Vyboh, Francisco García-de-Gracia, Ricardo Soto-Rifo, Andreas E Kulozik, Niels H Gehring, Andrew J Mouland

Open access · goldAbstract read
In one paragraph

Article in Biomolecules, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 42 papers.

0numbers the graph read from it
0cells of the map it votes in
42citing papers in PubMed
2.3field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

42 citing papers in PubMed, 67 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Review
  7. Review
  8. Review
  9. Review
  10. Review
  11. Article
  12. Review
  13. Review
  14. Review
  15. Article
  16. Review
  17. Article
  18. The human DEAD-box helicase DDX3X as a regulator of mRNA translation.Frontiers in cell and developmental biology · 2022
    Review
  19. HibeRNAtion: HIV-1 RNA Metabolism and Viral Latency.Frontiers in cellular and infection microbiology · 2022
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 3 countries.

Lara AjamianHIV-1 RNA Trafficking Laboratory, Lady Davis Institute for Medical Research-Sir Mortimer B. Davis Jewish General Hospital, Montréal QC H3T 1E2, Canada. lara.ajamian@mail.mcgill.ca.
Karen AbelHIV-1 RNA Trafficking Laboratory, Lady Davis Institute for Medical Research-Sir Mortimer B. Davis Jewish General Hospital, Montréal QC H3T 1E2, Canada. karen_abel@gmx.de.
Shringar RaoHIV-1 RNA Trafficking Laboratory, Lady Davis Institute for Medical Research-Sir Mortimer B. Davis Jewish General Hospital, Montréal QC H3T 1E2, Canada. shringar.rao@mail.mcgill.ca.
Kishanda VybohHIV-1 RNA Trafficking Laboratory, Lady Davis Institute for Medical Research-Sir Mortimer B. Davis Jewish General Hospital, Montréal QC H3T 1E2, Canada. kishanda.vyboh@mail.mcgill.ca.
Francisco García-de-GraciaLaboratory of Molecular and Cellular Virology, Virology Program, Biomedical Sciences Institute, Faculty of Medicine, Universidad de Chile, Independencia 8389100, Santiago, Chile. franciscogarcia96@gmail.com.
Ricardo Soto-RifoLaboratory of Molecular and Cellular Virology, Virology Program, Biomedical Sciences Institute, Faculty of Medicine, Universidad de Chile, Independencia 8389100, Santiago, Chile. rsotorifo@med.uchile.cl.
Andreas E KulozikDepartment of Pediatric Oncology, Hematology and Immunology, Heidelberg 69120, Germany. andreas.kulozik@med.uni-heidelberg.de.
Niels H GehringInstitute for Genetics, University of Cologne, Cologne 50674, Germany. ngehring@uni-koeln.de.
Andrew J MoulandHIV-1 RNA Trafficking Laboratory, Lady Davis Institute for Medical Research-Sir Mortimer B. Davis Jewish General Hospital, Montréal QC H3T 1E2, Canada. andrew.mouland@mcgill.ca.
Jewish General Hospital · CAUniversity of Chile · CLEuropean Molecular Biology Laboratory · DEUniversity of Cologne · DE

Funding

Canadian Institutes of Health Research MOP-38111Canadian Institutes of Health Research MOP-56974
6 · The paper itself

Abstract

Unspliced, genomic HIV-1 RNA (vRNA) is a component of several ribonucleoprotein complexes (RNP) during the viral replication cycle. In earlier work, we demonstrated that the host upframeshift protein 1 (UPF1), a key factor in nonsense-mediated mRNA decay (NMD), colocalized and associated to the viral structural protein Gag during viral egress. In this work, we demonstrate a new function for UPF1 in the regulation of vRNA nuclear export. OPEN ACCESS Biomolecules 2015, 5 2809 We establish that the nucleocytoplasmic shuttling of UPF1 is required for this function and demonstrate that UPF1 exists in two essential viral RNPs during the late phase of HIV-1 replication: the first, in a nuclear export RNP that contains Rev, CRM1, DDX3 and the nucleoporin p62, and the second, which excludes these nuclear export markers but contains Gag in the cytoplasm. Interestingly, we observed that both UPF2 and the long isoform of UPF3a, UPF3aL, but not the shorter isoforms UPF3aS and UPF3b, are excluded from the UPF1-Rev-CRM1-DDX3 complex as they are negative regulators of vRNA nuclear export. In silico protein-protein docking analyses suggest that Rev binds UPF1 in a region that overlaps the UPF2 binding site, thus explaining the exclusion of this negative regulatory factor by HIV-1 that is necessary for vRNA trafficking. This work uncovers a novel and unique regulatory circuit involving several UPF proteins that ultimately regulate vRNA nuclear export and trafficking.

Indexed as

Virus ReplicationActive Transport, Cell NucleusCell NucleusDEAD-box RNA HelicasesExportin 1 ProteinHeLa CellsHIV-1HumansKaryopherinsMembrane GlycoproteinsNuclear Pore Complex ProteinsProtein BindingReceptors, Cytoplasmic and Nuclearrev Gene Products, Human Immunodeficiency VirusRNA-Binding ProteinsRNA HelicasesDDX3X protein, humanDEAD-box RNA HelicasesExportin 1 ProteinKaryopherinsMembrane GlycoproteinsNuclear Pore Complex Proteinsnuclear pore protein p62Receptors, Cytoplasmic and Nuclearrev Gene Products, Human Immunodeficiency VirusRNA-Binding ProteinsRNA HelicasesRNA, ViralTrans-ActivatorsTranscription FactorsUPF1 protein, humanUPF2 protein, humanUPF3A protein, humanHIV-1nonsense mediated decaynuclear RNA exportribonucleoproteinUPF1viral evasion

Identifiers

PMID26492277
PMCPMC4693258
OpenAlexW1750901338

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.